See also this year's filing and all EDGAR filings for this company.
PDF Report 0001344413_2013_Alexza_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001344413, Alexza Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 23,618,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 16,531,000 |
| 3 | remainder_Assets | 402,000 |
| 4 | LiabilitiesCurrent | 18,718,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,093,000 |
| 9 | ResearchAndDevelopmentExpense | 21,849,000 |
| 10 | remainder_Expenses | 1,426,000 |
| 11 | remainder_Revenues | 4,070,000 |
| 12 | remainder_NetIncome | 2,320,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 40,551,000 |
| 1 | Liabilities | 18,718,000 |
| 2 | Expenses | 34,368,000 |
| 3 | Revenues | 4,070,000 |
| 4 | StockholdersEquity | 21,833,000 |
| 5 | NetIncome | -27,978,000 |
| 6 | ComprehensiveNetIncome | -27,978,000 |
| 7 | BaseVar | 50,013,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.662 |
| 9 | EconomicCapitalRatio | 2.02 |
Edgar->Model Mapping
Feature Distribution
